New study: can proton therapy spare women from bowel problems after cancer surgery?

NCT ID NCT04567771

First seen Nov 15, 2025 · Last updated Jun 23, 2026 · Updated 28 times

Summary

This study compares two types of radiation therapy—proton therapy and standard intensity-modulated radiation therapy (IMRT)—given after surgery for cervical or endometrial cancer. The goal is to see if proton therapy causes fewer bowel side effects. About 120 women will fill out quality-of-life questionnaires and have their side effects tracked. The results could help doctors choose the gentler treatment option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Mayo Clinic in Arizona

    Scottsdale, Arizona, 85259, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224-9980, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Radiation therapy (proton or intensity-modulated)

What this could lead to

If proton therapy causes fewer bowel side effects than standard IMRT, it could become a gentler option for women after surgery for cervical or endometrial cancer.

What could go wrong

This is a small early-phase study (120 people) comparing side effects, not testing a cure. Results may not show a clear benefit, and individual experiences vary.

Conditions

The condition(s) this trial relates to.

endometriosis endometrium neoplasm pelvic inflammatory disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.